DiaMedica Therapeutics News - DMAC

Company Name	Stock Ticker Symbol	Market	Type
DiaMedica Therapeutics Inc	DMAC	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.10	-4.02%	2.39	16:01:02

Open Price	Low Price	High Price	Close Price	Prev Close
2.47	2.37	2.5412	2.39	2.49

more quote information »

Recent News

Date	Time	Source	Heading
4/17/2024	16:08	BW	DiaMedica Therapeutics Announces First Patient Dosed in..
3/19/2024	16:15	BW	DiaMedica Therapeutics Provides a Business Update and..
1/29/2024	16:13	BW	DiaMedica Therapeutics Announces Poster Presentation at..
1/23/2024	16:23	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/23/2024	16:12	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
1/22/2024	08:23	BW	DiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as..
1/02/2024	17:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/02/2024	16:47	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/02/2024	16:39	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/02/2024	16:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/16/2023	16:37	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/13/2023	16:55	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/2023	16:52	EDGAR2	Form 8-K - Current report
11/13/2023	16:28	BW	DiaMedica Therapeutics Provides a Business Update and..
11/09/2023	08:25	BW	DiaMedica Therapeutics to Attend the 14th Annual..
11/06/2023	08:23	BW	DiaMedica Therapeutics to Report Third Quarter 2023..
9/12/2023	08:13	BW	DiaMedica Therapeutics Announces the Appointment of Ambarish..
9/06/2023	08:35	BW	DiaMedica Therapeutics to Participate at Lake Street’s 7th..
9/05/2023	16:15	EDGAR2	Form 8-K - Current report
8/14/2023	16:29	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/2023	16:25	EDGAR2	Form 8-K - Current report
8/14/2023	16:13	BW	DiaMedica Therapeutics Provides a Business Update and..
8/08/2023	08:32	BW	DiaMedica Therapeutics to Report Second Quarter 2023..
7/18/2023	08:30	BW	DiaMedica Therapeutics to Attend the American Academy of..
7/10/2023	16:16	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
7/10/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
6/30/2023	16:16	EDGAR2	Form S-3 - Registration statement under Securities Act of..
6/26/2023	08:30	BW	DiaMedica Therapeutics Announces Closing of $37.5 Million..
6/21/2023	08:39	BW	DiaMedica Therapeutics Announces $37.5 Million Private..
6/21/2023	08:15	BW	DiaMedica Therapeutics Announces that the FDA Has Removed..
5/30/2023	08:29	BW	DiaMedica Therapeutics Announces Appointment of Dr. Richard..
5/15/2023	16:28	BW	DiaMedica Therapeutics Provides a Business Update and..
5/08/2023	08:50	BW	DiaMedica Therapeutics to Report First Quarter 2023..